These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 2565965
21. Tricyclic antidepressants and monoamine oxidase inhibitors. Schuckit M, Robins E, Feighner J. Arch Gen Psychiatry; 1971 Jun; 24(6):509-14. PubMed ID: 5578096 [No Abstract] [Full Text] [Related]
22. A comparative study of the electrocardiographic effects of phenelzine, tricyclic antidepressants, mianserin, and placebo. McGrath PJ, Blood DK, Stewart JW, Harrison W, Quitkin FM, Tricamo E, Markowitz J. J Clin Psychopharmacol; 1987 Oct; 7(5):335-9. PubMed ID: 3680604 [Abstract] [Full Text] [Related]
23. THE ANTIDEPRESSANT DRUGS. HORDERN A. N Engl J Med; 1965 Jun 03; 272():1159-69. PubMed ID: 14284986 [No Abstract] [Full Text] [Related]
24. Effect of antidepressants and neuroleptics on phosphoinositide metabolism in human platelets. Pandey SC, Davis JM, Schwertz DW, Pandey GN. J Pharmacol Exp Ther; 1991 Mar 03; 256(3):1010-8. PubMed ID: 1672374 [Abstract] [Full Text] [Related]
25. The safety of switching rapidly from tricyclic antidepressants to monoamine oxidase inhibitors. Kahn D, Silver JM, Opler LA. J Clin Psychopharmacol; 1989 Jun 03; 9(3):198-202. PubMed ID: 2738181 [Abstract] [Full Text] [Related]
26. The mechanism of the potentiating effect of antidepressant drugs on the protective influenc oe of diphenhydramine in experimental catatonia. The role of histamine. Chopra YM, Dandiya PC. Pharmacology; 1974 Jun 03; 12(6):347-53. PubMed ID: 4477392 [Abstract] [Full Text] [Related]
27. Interactions between catecholamines and tricyclic and monoamine oxidase inhibitor antidepressive agents in man. Barar FS, Boakes AJ, Benedikter LB, Laurence DR, Prichard BN, Teoh PC. Br J Pharmacol; 1971 Oct 03; 43(2):472P-473P. PubMed ID: 5158242 [No Abstract] [Full Text] [Related]
28. Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant. McGrath PJ, Stewart JW, Nunes EN, Quitkin FM. J Clin Psychiatry; 1994 Aug 03; 55(8):336-9. PubMed ID: 8071301 [Abstract] [Full Text] [Related]
29. A clinical overview of monoamine oxidase inhibitors. Zisook S. Psychosomatics; 1985 Mar 03; 26(3):240-6, 251. PubMed ID: 3887453 [No Abstract] [Full Text] [Related]
30. Inhibition of human brain type B monoamine oxidase by tricyclic psychoactive drugs. Roth JA. Mol Pharmacol; 1978 Jan 03; 14(1):164-71. PubMed ID: 24168 [No Abstract] [Full Text] [Related]
31. Chronic administration of the antidepressant-antipanic drug phenelzine and its N-acetylated analogue: effects on monoamine oxidase, biogenic amines, and alpha 2-adrenoreceptor function. McKenna KF, Baker GB, Coutts RT, Greenshaw AJ. J Pharm Sci; 1992 Aug 03; 81(8):832-5. PubMed ID: 1383493 [Abstract] [Full Text] [Related]
32. Studies of monoamine oxidases. Inhibition of bovine brain MAO in intact mitochondria by tricyclic antidepressant drugs. Achee FM, Gabay S. Biochem Pharmacol; 1979 Apr 01; 28(7):1197-203. PubMed ID: 444277 [No Abstract] [Full Text] [Related]
33. The practical pharmacology of the psychoactive drugs. The antidepressants. Newgreen DB. Aust Fam Physician; 1980 Mar 01; 9(3):146-52. PubMed ID: 7369948 [Abstract] [Full Text] [Related]
34. Some biochemical aspects of the potential benefit of associating MD780515 with tricyclic antidepressants. Dostert P, Strolin Benedetti M, Sontag N. J Pharm Pharmacol; 1981 Oct 01; 33(10):639-43. PubMed ID: 6117616 [Abstract] [Full Text] [Related]
35. The influence of some MAO inhibitors and neuroleptics on enzymes concerned in GABA metabolism. Simánĕ Z, Kraus P. Act Nerv Super (Praha); 1968 Oct 03; 10(3):331. PubMed ID: 4387433 [No Abstract] [Full Text] [Related]